Press release
Multitargeted Therapies Promiscuous Drugs and Combination Therapies Market Industry Analysis, Trend and Growth, 2015-2021
A paradigm shift has been observed with respect to the development of effective therapies involving the use of complementary drug combinations. The main focus of such therapies is to target all the tumor components and impair their function. Tyrosine kinase receptors, mitochondria and microtubule networks are some of the most common targets of cancer cells. This novel approach helps in elucidating the effects of therapeutic combination on each tumor component and results in unveiling of new anti-cancer mechanisms. These anti-cancer mechanisms in turn pave the path for development of new drugs and strategies to tackle with the condition.Combination therapies are used against complex disorders that have multiple causes along with multiple targets and many small molecule drugs are capable of addressing multiple targets. Multitargeted therapies is the emerging discipline resulting from the combination of chemogenomics and network biology. The market for multitargeted therapies exhibits impressive growth due to effective treatment options, use of small molecule drugs effective against multiple targets and rise in the number of patients suffering from complex diseases such as cancer.
Request for Report TOC @ https://www.persistencemarketresearch.com/toc/5567
The market for multitargeted therapies can be segmented on the basis of the molecules used in the treatment and novel approaches towards development of novel combination therapies against multiple targets. Multitargeted protein kinase inhibitors are effective in treating chronic myelogenous leukemia. Synthetic lethality results from the combination of mutations in two or more genes leading to cell death. This approach is adopted to develop targeted therapies in order to reduce the off-target effects due to use of chemopreventative drugs and chemotherapies.
The major factors driving the growth of the market are constant rise in the number of cancer patients worldwide in conjunction with increasing preference for effective treatment options. In addition, introduction of novel drugs and technological advances will further fuel the market growth.
Request for Report Sample @ https://www.persistencemarketresearch.com/samples/5567
On the contrary, prolonged and tedious development phase followed by high costs of drug development process are some of the factors that might restrain the growth of the market.
About Us
Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.Our client success stories feature a range of clients from Fortune 500 companies to fast-growing startups. PMR’s collaborative environment is committed to building industry-specific solutions by transforming data from multiple streams into a strategic asset.
Contact Us
Persistence Market Research
305 Broadway,7th Floor
New York City, NY 10007
United States
Tel: +1-646-568-7751
Tollfree: +1 800-961-0353
Email: sales@persistencemarketresearch.com
Website: https://www.persistencemarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Multitargeted Therapies Promiscuous Drugs and Combination Therapies Market Industry Analysis, Trend and Growth, 2015-2021 here
News-ID: 758628 • Views: …
More Releases from Persistence Market Research
Blood Collection Tubes Market Size, Growth, Share & Trends 2025-2032 | Global In …
The blood collection tubes market plays a pivotal role in modern healthcare by enabling safe, efficient, and accurate collection, storage, and transportation of blood samples. Extensively used in diagnostic laboratories, hospitals, and research centers, these tubes are critical for hematology, biochemistry, immunology, and molecular testing. They help maintain sample integrity, minimize contamination risks, and streamline laboratory workflows, making them indispensable in clinical diagnostics.
Request a Sample:
https://www.persistencemarketresearch.com/samples/35126
Market Overview
According to a recent study…
Frozen Pastries Market to Reach $3.8 Bn by 2032 Driven by Convenience and Ready- …
The global frozen pastries market is set for consistent expansion over the next decade, driven by the growing demand for convenient, ready-to-bake bakery products and evolving consumer lifestyles. According to market projections, the global frozen pastries market size is likely to be valued at US$ 2.6 billion in 2025 and is estimated to reach US$ 3.8 billion by 2032, growing at a CAGR of 5.7% during the forecast period from…
Cookies Market to Reach US$ 54.4 Bn by 2032 Driven by Rising Demand for Premium …
The global cookies market is witnessing steady growth, with its valuation expected to reach US$ 38.3 billion in 2025. According to projections, the market is set to rise significantly and reach approximately US$ 54.4 billion by 2032, expanding at a compound annual growth rate (CAGR) of 5.1% between 2025 and 2032. This growth trajectory is fueled by evolving consumer lifestyles, increasing demand for convenient and on-the-go snacks, and the rising…
Flaxseeds Market Growth Driven by Health Trends | Valued at US$ 1,284.7 Mn in 20 …
The global flaxseeds market is witnessing substantial expansion, driven by the growing consumer awareness of health benefits associated with flaxseed consumption and its increasing use across diverse industries such as food and beverages, pharmaceuticals, and cosmetics. According to recent industry analysis, the global flaxseeds market size is likely to be valued at US$ 1,284.7 million in 2025, and is projected to reach US$ 2,145.3 million by 2032, expanding at a…
More Releases for Multitargeted
ALK-positive Non-Small Cell Lung Cancer Pipeline: Companies Advancing Targeted T …
The therapeutic landscape for ALK-positive Non-Small Cell Lung Cancer (ALK+ NSCLC), a genetically defined subset of lung cancer driven by ALK gene rearrangements, is undergoing a significant transformation. Biopharmaceutical companies are shifting focus from traditional chemotherapy to precision medicine approaches that directly inhibit ALK-driven oncogenic signaling. With multiple generations of ALK inhibitors now available and resistance mechanisms emerging, the spotlight is on next-generation inhibitors, combination regimens, and CNS-penetrant therapies designed…
Liver Cancer Drug Market - A Comprehensive Study by Key Players: Eisai, Exelixis …
Archive Market Research Released the latest study on Global Liver Cancer Drug Market Growth Outlook 2024-2032 provides an opportunity to better understand details about fundamental restructuring and growth prognosis in Online Apparel Market. This study offers current relevant facts and correlations and elaborates long-term, sustainable strategic and operative suggestions taken up by leading and emerging manufacturers. The sector faces an unprecedented change with regard to the far-reaching effects that it…
Pheochromocytoma Pipeline, Clinical Trials Assessment, NDA Approvals 2023 (Updat …
DelveInsight's, "Pheochromocytoma Pipeline Insight, 2023," report provides comprehensive insights about 8+ companies and 8+ pipeline drugs in the Pheochromocytoma pipeline landscape. It covers the Pheochromocytoma pipeline drug profiles, including Pheochromocytoma clinical trials and nonclinical stage products. It also covers the Pheochromocytoma pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
In the Pheochromocytoma Pipeline Report,…
Renal Cell Carcinoma Market Set to Experience Unprecedented Growth During the Fo …
As per DelveInsight, the Renal Cell Carcinoma Market is anticipated to evolve immensely in the coming years owing to the rise in the healthcare spending across the world, the increase in the number of cases of Renal Cell Carcinoma, and the launch of new therapies in the market.
DelveInsight's "Renal Cell Carcinoma Market Insights, Epidemiology, and Market Forecast 2032" report delivers an in-depth understanding of the disease, historical and forecasted…
Cattle Encephalon Glycoside and Ignotin Injection Market Size, Share 2022, Impre …
The global cattle encephalon glycoside and ignotin injection market is anticipated to grow at a CAGR of 3.4% during the forecast period (2022-2028).
Cattle encephalon glycoside and ignotin injection has been widely used in the treatment of central and peripheral nerve injuries. According to WHO, Dementia is a condition in which cognitive performance deteriorates beyond what would be expected as a result of normal biological aging. Dementia is not a…
Fecal Analyzer Market Growth Is Driven By Heska Corporation , AVE Science and Te …
A report by The Insight Partner's on the Fecal Analyzer Market discusses the growth of the market in great detail. It discusses thoroughly all factors promoting and deterring the market. The report also focuses on the competitive dynamics in the market by monitoring the strengths and weaknesses of prominent contributors and their key products.
The fecal analyzer market was valued at US$ 657.44million in 2019and is projected to reach US$ 842.48…
